A new study by researchers in Geisel’s Sundstrom Lab sheds new light on a previously little understood area of fungal biology and could lead to new treatments for dangerous fungal pathogens.
Post Tagged with: "research"
The Geisel School of Medicine and Dartmouth-Hitchcock are partnering with Brigham and Women’s Hospital as one of four centers in a new American Heart Association-funded research network charged with unlocking some of the mysteries behind vascular disease.
Christina Angeles, MD, assistant professor of surgery, has been selected as the recipient of the 2017-18 SYNERGY Scholars Mentored Career Development Award, funded through Dartmouth SYNERGY Clinical and Translational Science Institute.
Noted molecular biologist James Bliska, PhD, is joining the Geisel School of Medicine at Dartmouth as a Distinguished Professor in Microbiology and Immunology and senior lead faculty member of the Personalized Treatments for Cystic Fibrosis (CF) Cluster, a cross-Dartmouth group of investigators established to develop innovative, personalized medicine and treatments for CF and lung infections caused by opportunistic pathogens.
Two outstanding graduate student researchers at the Geisel School of Medicine, Heidi Chapman and Riley Hampsch, are gaining knowledge and skills in the biotechnology sector as recipients of 2017 Dartmouth SYNERGY/Celdara Medical High-Potential Entrepreneurs’ Fellowships.
This year’s Gear Up for Research will be held Monday, October 30th, from 11:00 AM- 1:00 PM, in Auditoria A-C at DHMC. Gear Up is an information fair that brings together entities that support research at Dartmouth and DHMC. It is here that researchers including faculty, residents, nurses, students, and postdocs, have the opportunity to learn about services, meet key people, ask questions, and get answers.
A team of Geisel researchers will receive funding from the Patient-Centered Outcomes Research Institute (PCORI) to design new methods for comparing the effectiveness of alternative therapies that can lead to improvements in practice and better outcomes for patients.
Dartmouth ranks highly in a new measure of the impact of academic research on global innovation, according to the Nature Index 2017 Innovation supplement. The index examines how often research articles from top science journals are cited in third-party patents around the world.
Michael Sporn, MD, emeritus professor of pharmacology and toxicology, and medicine, is featured in Nature Index 2017 for his tremendous impact upon biomedical research and drug development.
Morgan Gilman, a fourth-year graduate student in the McLellan Lab at Geisel, is helping lead efforts to understand how a particular type of protein allows deadly viruses—such as Ebola and RSV (respiratory syncytial virus)—to gain entry into host cells, and how antibodies can be developed to neutralize that process.